InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc., based in Vancouver, BC, is a clinical-stage pharmaceutical company focused on developing proprietary small molecule drug candidates targeting the CB1 and CB2 receptors. Their pipeline includes innovative programs for treating Alzheimer's disease, age-related macular degeneration, and epidermolysis bullosa, with promising preclinical and clinical results.
InMed's subsidiary, BayMedica, specializes in the production of high-purity rare cannabinoids for health and wellness products, leveraging advanced manufacturing techniques. The company is committed to advancing cannabinoid therapeutics, offering patentable analogs that may provide improved therapeutic effects compared to naturally occurring cannabinoids.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
